Background and Rationale: Immune checkpoint inhibitor (ICI) therapy is an expanding therapeutic option for hepatocellular carcinoma (HCC). Antibiotics (ATB) taken prior to or early during ICI therapy can impact immunotherapy efficacy across indications; however, the effect of ATB is undefined in HCC. Methods: In a large international cohort of 450 ICI recipients from Europe, North America, and Asia, we categorized patients according to timing of ATB focusing on exposure within -30 to +30 days from ICI (early immunotherapy period [EIOP]). EIOP was evaluated in association with overall survival (OS), progression-free survival (PFS), and best radiologic response using RECIST 1.1 criteria. Results: Our study comprised mostly cirrhotic (329, 73....
Immune checkpoint inhibitors (ICIs) are beginning to show promise in the clinical management of hepa...
Hepatocellular carcinoma (HCC) is one of the leading causes of death worldwide. The use of local tre...
Hepatocellular carcinoma (HCC) is one of the leading causes of death worldwide. The use of local tre...
Background and Rationale: Immune checkpoint inhibitor (ICI) therapy is an expanding therapeutic opti...
Background & Aims: Immune checkpoint inhibitors (ICIs) alone or in combination with other ICIs or va...
Background: Recent studies suggested that use of antibiotics may interfere with treatment responses ...
Purpose: The development of treatment-related adverse events (trAE) correlates favorably with clinic...
Introduction: Development of immune-related adverse events (irAEs) has been associated with enhanced...
Background and AimImmune checkpoint inhibitors (ICIs) have been widely used in hepatocellular carcin...
Background & Aims: We investigated the efficacy and safety of immune checkpoint inhibitor (ICI) rech...
: The systemic treatment of hepatocellular carcinoma (HCC) is changing rapidly. After a decade of ty...
Background: Antibiotic exposure has been associated with worse outcomes with immune checkpoint inhib...
The implementation of immune checkpoint inhibitors (ICI) into the clinical management of different m...
The impact of corticosteroid therapy (CT) on efficacy of immune checkpoint inhibitors (ICI) is undef...
The treatment landscape of advanced hepatocellular carcinoma (HCC) has broadened with immune checkpo...
Immune checkpoint inhibitors (ICIs) are beginning to show promise in the clinical management of hepa...
Hepatocellular carcinoma (HCC) is one of the leading causes of death worldwide. The use of local tre...
Hepatocellular carcinoma (HCC) is one of the leading causes of death worldwide. The use of local tre...
Background and Rationale: Immune checkpoint inhibitor (ICI) therapy is an expanding therapeutic opti...
Background & Aims: Immune checkpoint inhibitors (ICIs) alone or in combination with other ICIs or va...
Background: Recent studies suggested that use of antibiotics may interfere with treatment responses ...
Purpose: The development of treatment-related adverse events (trAE) correlates favorably with clinic...
Introduction: Development of immune-related adverse events (irAEs) has been associated with enhanced...
Background and AimImmune checkpoint inhibitors (ICIs) have been widely used in hepatocellular carcin...
Background & Aims: We investigated the efficacy and safety of immune checkpoint inhibitor (ICI) rech...
: The systemic treatment of hepatocellular carcinoma (HCC) is changing rapidly. After a decade of ty...
Background: Antibiotic exposure has been associated with worse outcomes with immune checkpoint inhib...
The implementation of immune checkpoint inhibitors (ICI) into the clinical management of different m...
The impact of corticosteroid therapy (CT) on efficacy of immune checkpoint inhibitors (ICI) is undef...
The treatment landscape of advanced hepatocellular carcinoma (HCC) has broadened with immune checkpo...
Immune checkpoint inhibitors (ICIs) are beginning to show promise in the clinical management of hepa...
Hepatocellular carcinoma (HCC) is one of the leading causes of death worldwide. The use of local tre...
Hepatocellular carcinoma (HCC) is one of the leading causes of death worldwide. The use of local tre...